{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T12:21:22Z","timestamp":1696681282330},"reference-count":47,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej19-0501","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T22:04:59Z","timestamp":1598997899000},"page":"1207-1214","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic significance of apical membranous and cytoplasmic dot-like CD26 expression in encapsulated follicular variant of papillary thyroid carcinoma: a useful marker for capsular invasion"],"prefix":"10.1507","volume":"67","author":[{"given":"Shoji","family":"Takagi","sequence":"first","affiliation":[{"name":"Department of Medical Life Science, Kurashiki University of Science and the Arts, Kurashiki, Okayama 712-8505, Japan"},{"name":"Faculty of Medicine, Graduate School of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Hirokawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Gifu University Hospital, Gifu, Gifu 501-1194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyoko","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyuichi","family":"Kadota","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryou","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Medical Life Science, Kurashiki University of Science and the Arts, Kurashiki, Okayama 712-8505, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kuma Hospital, Kobe, Hyogo 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Miyake","sequence":"additional","affiliation":[{"name":"Department of Medical Life Science, Kurashiki University of Science and the Arts, Kurashiki, Okayama 712-8505, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiji","family":"Haba","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, et al. (2009) International patterns and trends in thyroid cancer incidence, 1973\u20132002. Cancer Causes Control 20: 525\u2013531.","DOI":"10.1007\/s10552-008-9260-4"},{"key":"2","unstructured":"2 Jung CK, Little MP, Lubin JH, Brenner AV, Wells SA Jr, et al. (2014) The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol Metab 99: E276\u2013E285."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Schneider DF, Elfenbein D, Lloyd RV, Chen H, Sipppel RS (2015) Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer. Ann Surg Oncol 22: 158\u2013163.","DOI":"10.1245\/s10434-014-3964-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Chem KT, Rosai J (1977) Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am J Surg Pathol 1: 123\u2013130.","DOI":"10.1097\/00000478-197706000-00003"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Liu J, Singh B, Tallini G, Carlson DL, Katabi N, et al. (2006) Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107: 1255\u20131264.","DOI":"10.1002\/cncr.22138"},{"key":"6","unstructured":"6 Nguyen QT, Lee EJ, Huang MG, Park YI, Khullar A, et al. (2015) Diagnosis and treatment of patients with thyroid cancer. Am Health Drug Benefits 8: 30\u201340."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, et al. (2016) Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2: 1023\u20131029.","DOI":"10.1001\/jamaoncol.2016.0386"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Elsheikh TM, Asa SL, Chan JK, DeLellis RA, Heffess CS, et al. (2008) Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol 130: 736\u2013744.","DOI":"10.1309\/AJCPKP2QUVN4RCCP"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Itou M, Kawaguchi T, Taniguchi E, Sata M (2013) Dipeptidyl peptidase-4: a key player in chronic liver disease. World J Gastroenterol 19: 2298\u20132306.","DOI":"10.3748\/wjg.v19.i15.2298"},{"key":"10","unstructured":"10 Doonan BP, Ohnuma K, Dang LH, Morimoto C, Dang NH (2017) Current and emerging therapy for malignant pleural mesothelioma: focus on CD26\/dipeptidyl peptidase IV as a therapeutic target. Curr Med Chem 13: 76\u201388."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Piazza GA, Callanan HM, Mowery J, Hixson DC (1989) Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem J 262: 327\u2013334.","DOI":"10.1042\/bj2620327"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Cheng HC, Abdel-Ghany M, Pauli BU (2003) A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J Biol Chem 278: 24600\u201324607.","DOI":"10.1074\/jbc.M303424200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Morrison ME, Vijayasaradhi S, Engelstein D, Albino AP, Houghton AN (1993) A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med 177: 1135\u20131143.","DOI":"10.1084\/jem.177.4.1135"},{"key":"14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00125-005-0107-1","volume":"49","author":"JJ Holst","year":"2006","unstructured":"14 Holst JJ (2006) Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005. Diabetologia 49: 253\u2013260.","journal-title":"Diabetologia","ISSN":"http:\/\/id.crossref.org\/issn\/0012-186X","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Yu DM, Yao TW, Chowdhury S, Nadvi NA, Osborne B, et al. (2010) The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J 277: 1126\u20131144.","DOI":"10.1111\/j.1742-4658.2009.07526.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17 Leccia F, Nardone A, Corvigno S, Vecchio LD, De Placido S, et al. (2012) Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes. Cytometry A 81: 960\u2013972.","DOI":"10.1002\/cyto.a.22095"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18 Aoe K, Amatya VJ, Fujimoto N, Ohnuma K, Hosono O, et al. (2012) CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma. Clin Cancer Res 18: 1447\u20131456.","DOI":"10.1158\/1078-0432.CCR-11-1990"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Kotani T, Aratake Y, Ogata Y, Umeki K, Araki Y, et al. (1991) Expression of dipeptidyl aminopeptidase IV activity in thyroid carcinoma. Cancer Lett 57: 203\u2013208.","DOI":"10.1016\/0304-3835(91)90158-E"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20 Aratake Y, Kotani T, Tamura K, Araki Y, Kuribayashi T, et al. (1991) Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases. Am J Clin Pathol 96: 306\u2013310.","DOI":"10.1093\/ajcp\/96.3.306"},{"key":"20","unstructured":"21 Kotani T, Kawano J, Suganuma T, Hirai K, Umeki K, et al. (1992) Immunohistochemical localization of dipeptidyl aminopeptidase IV in thyroid papillary carcinoma. Int J Exp Pathol 73: 215\u2013222."},{"key":"21","doi-asserted-by":"crossref","unstructured":"22 Tanaka T, Umeki K, Yamamoto I, Sakamoto F, Noguchi S, et al. (1995) CD26 (dipeptidyl peptidase IV\/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Int J Cancer 64: 326\u2013331.","DOI":"10.1002\/ijc.2910640508"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23 Umeki K, Tanaka T, Yamamoto I, Aratake Y, Kotani T, et al. (1996) Differential expression of dipeptidyl peptidase IV (CD26) and thyroid peroxidase in neoplastic thyroid tissues. Endocr J 43: 53\u201360.","DOI":"10.1507\/endocrj.43.53"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24 Aratake Y, Umeki K, Kiyoyama K, Hinoura Y, Sato S, et al. (2002) Diagnostic utility of galectin-3 and CD26\/DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn Cytopathol 26: 366\u2013372.","DOI":"10.1002\/dc.10111"},{"key":"24","unstructured":"25 Kholov\u00e1 I, Ludv\u00edkov\u00e1 M, Ryska A, Hanzelkov\u00e1 Z, Cap J, et al. (2003) Immunohistochemical detection of dipeptidyl peptidase IV (CD 26) in thyroid neoplasia using biotinylated tyramine amplification. Neoplasma 50: 159\u2013164."},{"key":"25","doi-asserted-by":"crossref","unstructured":"26 Song Y, Zhou M, Cao Y, Qi J, Geng J, et al. (2017) Expression of GLP-1 receptor and CD26 in human thyroid C-cells: the association of thyroid C-cell tumorigenesis with incretin-based medicine. Oncol Lett 13: 2684\u20132690.","DOI":"10.3892\/ol.2017.5752"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27 Kotani T, Asada Y, Aratake Y, Umeki K, Yamamoto I, et al. (1992) Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumors. J Pathol 168: 41\u201345.","DOI":"10.1002\/path.1711680108"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28 Zhang M, Xu L, Wang X, Sun B, Ding J (2015) Expression levels of seprase\/FAP\u03b1 and DPPIV\/CD26 in epithelial ovarian carcinoma. Oncol Lett 10: 34\u201342.","DOI":"10.3892\/ol.2015.3151"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29 Hirokawa M, Higuchi M, Suzuki A, Hayashi T, Kuma S, et al. (2017) Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan. Endocr J 64: 1149\u20131155.","DOI":"10.1507\/endocrj.EJ17-0214"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30 Alves VAF, K Kakudo, LiVolsi V, Lloyd RV, Nikiforov YE, et al. (2018) Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): achieving better agreement by refining diagnostic criteria. Clinics (Sao Paulo) 73: e576.","DOI":"10.6061\/clinics\/2018\/e576"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31 Koshikawa T, Fujita N, Ueda N, Ota Y, Sasaki E, et al. (2019) Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features. Endocr J 66: 475\u2013483.","DOI":"10.1507\/endocrj.EJ18-0525"},{"key":"31","unstructured":"32 Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image Processing with ImageJ. Biophotonics Int 11: 36\u201342."},{"key":"32","doi-asserted-by":"crossref","unstructured":"33 Liu Z, Bychkov A, Jung CK, Hirokawa M, Sui S, et al. (2019) Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Pathol Int 69: 202\u2013210.","DOI":"10.1111\/pin.12779"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34 Higuchi M, Hirokawa M, Kanematsu R, Tanaka A, Suzuki A, et al. (2018) Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan. Endocr J 65: 1193\u20131198.","DOI":"10.1507\/endocrj.EJ18-0290"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35 Hegen M, Niedobitek G, Klein CE, Stein H, Fleischer B (1990) The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol 144: 2908\u20132914.","DOI":"10.4049\/jimmunol.144.8.2908"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36 Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C (1990) Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation <i>via<\/i> CD3 and CD2 pathways. J Immunol 144: 4092\u20134100.","DOI":"10.4049\/jimmunol.144.11.4092"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37 Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, et al. (2000) Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci U S A 97: 6874\u20136879.","DOI":"10.1073\/pnas.120069197"},{"key":"37","doi-asserted-by":"publisher","unstructured":"38 Waget A, Cabou C, Masseboeuf M, Cattan P, Armanet M, et al. (2011) Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. Endocrinology 152: 3018\u20133029.","DOI":"10.1210\/en.2011-0286"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39 Zheng B, Liu J, Gu J, Lu Y, Zhang W, et al. (2015) A three-gene panel that distinguishes benign from malignant thyroid nodules. Int J Cancer 136: 1646\u20131654.","DOI":"10.1002\/ijc.29172"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40 Kiyoyama K, Aratake Y, Shirahama K, Terada K, Sato S et al. (2013) CD26\/DPP IV is a useful marker for evaluation of the grade of differentiation in thyroid cancer. J Jpn Soc Clin Cytol 52: 422\u2013427 (In Japanese).","DOI":"10.5795\/jjscc.52.422"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41 Wesley UV, Albino AP, Tiwari S, Houghton AN (1999) A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 190: 311\u2013322.","DOI":"10.1084\/jem.190.3.311"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42 Hayashi M, Madokoro H, Yamada K, Nishida H, Morimoto C, et al. (2016) A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma <i>via<\/i> retarded G2\/M cell cycle transition. Cancer Cell Int 16: 35.","DOI":"10.1186\/s12935-016-0310-9"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43 Lee JJ, Wang TY, Liu CL, Chien MN, Chen MJ, et al. (2017) Dipeptidyl peptidase IV as a prognostic marker and therapeutic target in papillary thyroid carcinoma. J Clin Endocrinol Metab 102: 2930\u20132940.","DOI":"10.1210\/jc.2017-00346"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44 Xu B, Yoshimoto K, Miyauchi A, Kuma S, Mizusawa N, et al. (2003) Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the \u03b2-catenin gene. J Pathol 199: 58\u201367.","DOI":"10.1002\/path.1225"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45 Tanaka S, Sato K, Mori M, Sugimachi K (2000) Identification of a novel molecular target that regulates metastasis of human esophageal carcinoma. Nihon Shokaki Geka Gakkai Zasshi 33: 529\u2013532 (In Japanese).","DOI":"10.5833\/jjgs.33.529"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46 Zhu Y, Li Y, Jung CK, Song DE, Hang JF, et al. (2020) Histopathologic assessment of capsular invasion in follicular thyroid neoplasms-an observer variation study. Endocr Pathol 31: 132\u2013140.","DOI":"10.1007\/s12022-020-09620-7"},{"key":"46","doi-asserted-by":"publisher","unstructured":"47 Cipriani NA, Nagar S, Kaplan SP, White MG, Antic T, et al. (2015) Follicular thyroid carcinoma: how have histologic diagnoses changed in the last half-century and what are the prognostic implications? Thyroid 25: 1209\u20131216.","DOI":"10.1089\/thy.2015.0297"},{"key":"47","doi-asserted-by":"publisher","unstructured":"48 Hirokawa M, Higuchi M, Suzuki A, Hayashi T, Kuma S, et al. (2020) Prevalence and diagnostic significance of noninvasive follicular thyroid neoplasm with papillary-like nuclear features among tumors previously diagnosed as follicular adenoma: a single-institutional study in Japan. Endocr J doi:10.1507\/endocrj.EJ20-0198","DOI":"10.1507\/endocrj.EJ20-0198"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/12\/67_EJ19-0501\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T18:08:53Z","timestamp":1696615733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/12\/67_EJ19-0501\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0501","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}